Zobrazeno 1 - 10
of 553
pro vyhledávání: '"Crisaborole"'
Autor:
Huachun Wang, Hetong Li, Zhengxiao Li, Xiaomei Zhao, Xiaoli Hou, Lu Chen, Lei Xing, Faming Tian
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract This study evaluated the therapeutic efficacy and underlying mechanisms of crisaborole combined with vitamin D in the treatment of allergic contact dermatitis. While crisaborole, a phosphodiesterase 4 inhibitor, and vitamin D analogs are com
Externí odkaz:
https://doaj.org/article/674c5e520fe6404b95daa73cc69e09cc
Publikováno v:
Journal of Inflammation Research, Vol Volume 17, Pp 3419-3422 (2024)
Xu Liu,1,* Qingfeng Liu,1,* Linghong Guo,1 Xian Jiang1,2 1Department of Dermatology, West China Hospital, Sichuan University, Chengdu, People’s Republic of China; 2Laboratory of Dermatology, Clinical Institute of Inflammation and Immunology
Externí odkaz:
https://doaj.org/article/611a1326bd2f4737a12d8a55cd2a1e7b
Autor:
Lin Ma, Xiaohua Tao, Sujun Liu, Hao Cheng, Ruihua Fang, Yan Zhao, Amy Cha, Gerardo A. Encinas, Yangmei Zhou, Yujie Deng, Jianzhong Zhang
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 5, Pp 1229-1243 (2024)
Abstract Introduction Atopic dermatitis (AD) is a chronic immuno-inflammatory skin disease. Crisaborole ointment, 2%, is a nonsteroidal phosphodiesterase 4 inhibitor approved for the treatment of mild to moderate AD. This post hoc analysis assesses t
Externí odkaz:
https://doaj.org/article/cf6115b0bfe14273b01cd0c38fa7a173
Autor:
Lawrence F. Eichenfield, Linda F. Stein Gold, Charles Lynde, Lyn Guenther, Shoshana Greenberger, Chia-Yu Chu, Zara Ghodsi, Bonnie Vlahos, Paul Sanders, Amy Cha, Juliana M. Canosa
Publikováno v:
Dermatology and Therapy, Vol 14, Iss 4, Pp 875-892 (2024)
Abstract Introduction Treatments for atopic dermatitis (AD) often fail to achieve lasting disease control. In the CrisADe CONTROL phase III study (ClinicalTrials.gov: NCT04040192), participants aged ≥ 3 months with mild to moderate AD treated with
Externí odkaz:
https://doaj.org/article/41effdeed3974badbe06242737e93fe9
Publikováno v:
Xin yixue, Vol 54, Iss 7, Pp 527-530 (2023)
Acneiform rash is a chronic inflammatory skin disease involving hair follicle and sebaceous glands, primarily manifested with papules, pustules, cysts and nodules, accompanied by obvious pruritus. Here, we reported a 61-year-old female lung
Externí odkaz:
https://doaj.org/article/197c88f90ffb44f88cf6275545b34d78
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 1893-1897 (2023)
Yimin Liang,* Jingyao Liang,* Qiongxiao Huang, Xin Tian, Lei Shao, Manqi Xia, Yumei Liu Institute of Dermatology, Guangzhou Medical University, Department of Dermatology, Guangzhou Institute of Dermatology, Guangzhou, People’s Republic of C
Externí odkaz:
https://doaj.org/article/e830ca991a7645529e1dd0953d8a25d5
Publikováno v:
Dermatology Practical & Conceptual, Vol 13, Iss 4 (2023)
Introduction: Atopic dermatitis (AD) causes dry and itchy skin and inflammation that severely impairs the quality of life of affected children and adults. While topical glucocorticosteroid application is typically the first-line treatment of choice,
Externí odkaz:
https://doaj.org/article/3d98ce630534459fa5c04af0f05ba7b0
Autor:
Joseph Fowler, Jeffrey Sugarman, Lawrence Sher, Chuanbo Zang, John L. Werth, Daniela E. Myers, Daniela Graham, Alexander Agyei Marfo, Liza Takiya
Publikováno v:
Dermatology and Therapy, Vol 13, Iss 4, Pp 951-960 (2023)
Plain Language Summary Atopic dermatitis (AD), also known as eczema, is a chronic skin disease that causes red or flaky skin patches that can become infected and itch. Children with AD often experience sleep disturbance, including difficulty falling
Externí odkaz:
https://doaj.org/article/9f3154ed08464b0a9bf4d464568f6ef9
Autor:
Darya Pavlenko, Zeynep Todurga Seven, Lauren Bystrom, Anika Markan, Rebecca Verpile, Hirotake Ishida, Tasuku Akiyama
Publikováno v:
Acta Dermato-Venereologica, Vol 103 (2023)
Crisaborole, a phosphodiesterase 4 (PDE4) inhibitor, has been approved for the treatment of mild to moderate atopic dermatitis. Atopic dermatitis is often associated with increased pain. Using a mouse model, this study investigated whether crisaborol
Externí odkaz:
https://doaj.org/article/1a00783e73754134b5204e26e3f21f01
Autor:
Erika L. Crowley, Melinda J. Gooderham
Publikováno v:
Pharmaceutics, Vol 16, Iss 1, p 23 (2023)
Psoriasis is a common chronic immune-mediated disease with many comorbidities and impacts on quality of life. Among the treatments for psoriasis, phosphodiesterase-4 (PDE4) inhibitors are emerging with expanding options. PDE4 inhibitors play a pivota
Externí odkaz:
https://doaj.org/article/1e0e3b8c76b145bf8f47f9b2bb9ad716